New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies.
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies. Blood cancer discovery Ribas, A., Dhodapkar, M. V., Campbell, K. M., Davies, F. E., Gore, S. D., Levy, R., Greenberger, L. M. 2021; 2 (6): 562-567Abstract
Patients with hematologic malignancies are particularly vulnerable to COVID-19 infections, and upon a pooled data analysis of 24 publications, there is evidence that they have suboptimal antibody responses to COVID-19 vaccination and boosters. To provide them the needed additional protection from COVID-19, it is imperative to achieve a 100% full immunization rate in health care workers and adult caretakers, and to foster research to test higher doses and repeated rounds of COVID-19 vaccines and the use of passive immune prophylaxis and therapy.
View details for DOI 10.1158/2643-3230.BCD-21-0166
View details for PubMedID 34778796
View details for PubMedCentralID PMC8580613